Volume 5, Number 1—February 1999
Perspective
The Economic Impact of Staphylococcus aureus Infection in New York City Hospitals
Table 4
Incidence, length of stay, costs, and death rates of Staphylococcus aureus infections by type of infection
| Direct Medical Costs |
||||||
|---|---|---|---|---|---|---|
| Type of infection | Incidence | Length of stay (days) | Total ($M) | Per patient ($) | Deaths |
|
| Total | % | |||||
| Pneumonia | 3,600 | 22.2 | 128.3 | 35,400 | 890 | 25 |
| Bacteremia | 4,400 | 18.0 | 137.0 | 31,300 | 470 | 11 |
| Endocarditis | 550 | 25.9 | 25.8 | 47,200 | 40 | 7 |
| Surgical site infection | 2,300 | 13.6 | 50.5 | 21,800 | NDa | ND |
| Osteomyelitis | 2,000 | 23.9 | 68.4 | 35,000 | ND | ND |
| Septic arthritis | 700 | 22.0 | 25.5 | 35,100 | ND | ND |
| Total or average | 13,550 | 19.8 | 435.5 | 32,100 | 1,400 | 10 |
aND=no data.
Page created: December 07, 2010
Page updated: December 07, 2010
Page reviewed: December 07, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.